Molecular Endocrinology Group, Department of Medicine and Medical Research Council Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, London W12 0NN, UK.
J Endocrinol. 2011 Jun;209(3):261-72. doi: 10.1530/JOE-10-0448. Epub 2011 Feb 3.
The thyroid gland predominantly secretes the pro-hormone thyroxine (T(4)) that is converted to the active hormone 3,5,3'-l-triiodothyronine (T(3)) in target cells. Conversion of T(4) to T(3) is catalyzed by the type 2 iodothyronine deiodinase enzyme (DIO2), and T(3) action in target tissues is determined by DIO2-regulated local availability of T(3) to its nuclear receptors, TRα and TRβ. Studies of Dio2 knockout mice have revealed new and important roles for the enzyme during development and in adulthood in diverse tissues including the cochlea, skeleton, brown fat, pituitary, and hypothalamus. In this review, we discuss the molecular mechanisms by which DIO2 controls intracellular T(3) availability and action.
甲状腺主要分泌前激素甲状腺素 (T(4)),该激素在靶细胞中转化为活性激素 3,5,3'-l-三碘甲状腺原氨酸 (T(3))。T(4)向 T(3)的转化由 2 型碘甲状腺原氨酸脱碘酶 (DIO2) 催化,而 T(3)在靶组织中的作用则由 DIO2 调节的 T(3)向其核受体 TRα 和 TRβ 的局部可用性决定。对 Dio2 基因敲除小鼠的研究揭示了该酶在发育过程中和成年后在包括耳蜗、骨骼、棕色脂肪、垂体和下丘脑在内的各种组织中的新的和重要作用。在这篇综述中,我们讨论了 DIO2 控制细胞内 T(3)可用性和作用的分子机制。